Vaxil Bio is First Israeli Biotech to List on TSX-Venture

Vaxil Bio Ltd. (TSXV: VXL) announced the closing of its go-public via reverse takeover of Emerge Resources Corp., following overwhelming approval of the Transaction and related matters by the shareholders of both companies.
According to the news:

Vaxil’s shares are now trading under the symbol VXL. At a deemed value of $0.23 per share, the Company’s market value is approximately $11-Million. The Company’s financing and go-public were led by Sunel Securities Inc.

Click here to view the full press release.